MedPath

Towards Individualized Surgery in Non-focal Congenital Hyperinsulinism

Completed
Conditions
Non-focal Congenital Hyperinsulinism
Registration Number
NCT02108730
Lead Sponsor
University Medicine Greifswald
Brief Summary

Observational study in patients with non-focal congenital hyperinsulinism showing that restrictive surgery may improve the metabolic situation

Detailed Description

In non-focal congenital hyperinsulinism (CHI) the current doctrine warrants subtotal pancreatic resection in all children who do not respond to medication. However, the rate of diabetes after these extensive resections is very high. In this study investigators show that a less aggressive approach may suffice to wean many children from all medication or to get them manageable medically.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria
  • patients with non-focal congenital hyperinsulinism
Exclusion Criteria
  • patients with focal congenital hyperinsulinism

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
necessity of medication after restrictive surgery in congenital hyperinsulinismup to 3 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Pediatric Surgery

🇩🇪

Greifswald, Germany

Pediatric Surgery
🇩🇪Greifswald, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.